Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7120-7126

  Olivares Zavaleta, Norma ^a   Carmody, Aaron ^a   Messer, Ronald ^a   Whitmire, William M ^a   Caldwell, Harlan D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

APOPTOSIS; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CELL VIABILITY; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ENZYME SYNTHESIS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SENSITIVITY ANALYSIS; TISSUE INJURY;

APOPTOSIS; CELL PROLIFERATION; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 79959572202     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100393     Document Type: Article

References (40)

1. Carter, J. D., H. C. Gérard, L. R. Espinoza, L. R. Ricca J. Valeriano, J. Snelgrove, C. Oszust, F. B. Vasey, and A. P. Hudson. 2009. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 60: 1311-1316.
2. Watson, C., and N. J. Alp. 2008. Role of Chlamydia pneumoniae in atherosclerosis. Clin. Sci. 114: 509-531.
3. Bauer, R. W., L. R. Harrison, C. W. Watson, E. L. Styer, and W. L. Chapman, Jr. 1993. Isolation of Acanthamoeba sp. from a greyhound with pneumonia and granulomatous amebic encephalitis. J. Vet. Diagn. Invest. 5: 386-391.
4. MacDowell, A. L., and L. B. Bacharier. 2005. Infectious triggers of asthma. Immunol. Allergy Clin. North Am. 25: 45-66.
5. Blasi, F., P. Tarsia, and S. Aliberti. 2009. Chlamydophila pneumoniae. Clin. Microbiol. Infect. 15: 29-35.
6. Stallings, T. L. 2008. Association of Alzheimer's disease and Chlamydophila pneumoniae. J. Infect. 56: 423-431.
7. Bodetti, T. J., E. Jacobson, C. Wan, L. Hafner, A. Pospischil, K. Rose, and P. Timms. 2002. Molecular evidence to support the expansion of the hostrange of Chlamydophila pneumoniae to include reptiles as well as humans, horses, koalas and amphibians. Syst. Appl. Microbiol. 25: 146-152.
8. Gaydos, C. A., J. T. Summersgill, N. N. Sahney, J. A. Ramirez, and T. C. Quinn. 1996. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64: 1614-1620.
9. Jahn, H. U., M. Krüll, F. N. Wuppermann, A. C. Klucken, S. Rosseau, J. Seybold, J. H. Hegemann, C. A. Jantos, and N. Suttorp. 2000. Infection and activation of airway epithelial cells by Chlamydia pneumoniae. J. Infect. Dis. 182: 1678-1687.
10. Takano, R., H. Yamaguchi, S. Sugimoto, S. Nakamura, H. Friedman and Y. Yamamoto. 2005. Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae. Curr. Microbiol. 50: 160-166.
11. Puolakkainen, M. 2009. Innate immunity and vaccines in chlamydial infection with special emphasis on Chlamydia pneumoniae. FEMS Immunol. Med. Microbiol. 55: 167-177.
12. Redecke, V., K. Dalhoff, S. Bohnet, J. Braun, and M. Maass. 1998. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am. J. Respir. Cell Mol. Biol. 19: 721-727.
13. Högdahl, M., G. Söderlund, and E. Kihlström. 2008. Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (Chlamydophila) pneumoniae. APMIS 116: 1082-1088.
14. Ausiello, C. M., G. Fedele, R. Palazzo, F. Spensieri, A. Ciervo, and A. Cassone. 2006. 60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells. Microbes Infect. 8: 714-720.
15. Rajalingam, K., H. Al-Younes, A. Müller, T. F. Meyer, A. J. Szczepek, and T. Rudel. 2001. Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect. Immun. 69: 7880-7888.
16. Wahl, C., F. Oswald, U. Simnacher, S. Weiss, R. Marre, and A. Essig. 2001. Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect. Immun. 69: 7039-7045.
17. van Zandbergen, G., J. Gieffers, H. Kothe, J. Rupp, A. Bollinger, E. Aga, M. Klinger, H. Brade, K. Dalhoff, M. Maass, et al. 2004. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J. Immunol. 172: 1768-1776. (Pubitemid 38116825)
18. Goth, S. R., and R. S. Stephens. 2001. Rapid, transient phosphatidylserine externalization induced in host cells by infection with Chlamydia spp. Infect. Immun. 69: 1109-1119.
19. Dumrese, C., C. F. Maurus, D. Gygi, M. K. Schneider, M. Walch, P. Groscurth, and U. Ziegler. 2005. Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cells. BMC Microbiol. 5: 2.
20. Yaraei, K., L. A. Campbell, X. Zhu, W. C. Liles, C. C. Kuo, and M. E. Rosenfeld. 2005. Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway. Infect. Immun. 73: 4315-4322.
21. Sessa, R., M. Di Pietro, G. Schiavoni, A. Macone, B. Maras, M. Fontana, C. Zagaglia, M. Nicoletti, M. Del Piano, and S. Morrone. 2009. Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha. Int. J. Immunopathol. Pharmacol. 22: 659-668.
22. Caldwell, H. D., J. Kromhout, and J. Schachter. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31: 1161-1176.
23. Kobayashi, S. D., K. R. Braughton, A. R. Whitney, J. M. Voyich, T. G. Schwan, J. M. Musser, and F. R. DeLeo. 2003. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc. Natl. Acad. Sci. USA 100: 10948-10953.
24. Carabeo, R. A., S. S. Grieshaber, E. Fischer, and T. Hackstadt. 2002. Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect. Immun. 70: 3793-3803.
25. Duprez, L., E. Wirawan, T. Vanden Berghe, and P. Vandenabeele. 2009. Major cell death pathways at a glance. Microbes Infect. 11: 1050-1062.
26. Bergsbaken, T., S. L. Fink, and B. T. Cookson. 2009. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7: 99-109.
27. Dinarello, C. A. 1999. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103: 11-24.
28. Hirai, I., M. Utsumi, H. Yamaguchi, and Y. Yamamoto. 2010. Chlamydia pneumoniae infection suppresses Staphylococcus enterotoxin B-induced proliferation associated with down-expression of CD25 in lymphocytes. Can. J. Microbiol. 56: 289-294.
29. Yamaguchi, H., J. Matsuo, S. Sugimoto, M. Utsumi, and Y. Yamamoto. 2008. Inhibition of lymphocyte CD3 expression by Chlamydophila pneumoniae infection. Microb. Pathog. 45: 290-296.
30. Brunham, R. C., and J. Rey-Ladino. 2005. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5: 149-161.
31. Kalman, S., W. Mitchell, R. Marathe, C. Lammel, J. Fan, R. W. Hyman, L. Olinger, J. Grimwood, R. W. Davis, and R. S. Stephens. 1999. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21: 385-389.
32. Sundrud, M. S., V. J. Torres, D. Unutmaz, and T. L. Cover. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. USA 101: 7727-7732.
33. Torres, V. J., S. E. VanCompernolle, M. S. Sundrud, D. Unutmaz and T. L. Cover. 2007. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J. Immunol. 179: 5433-5440.
34. Peters, J., D. P. Wilson, G. Myers, P. Timms, and P. M. Bavoil. 2007. Type III secretion à la Chlamydia. Trends Microbiol. 15: 241-251.
35. Slepenkin, A., V. Motin, L. M. de la Maza, and E. M. Peterson. 2003. Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect. Immun. 71: 2555-2562.
36. Lutter, E. I., C. Bonner, M. J. Holland, R. J. Suchland, W. E. Stamm, T. J. Jewett, G. McClarty, and T. Hackstadt. 2010. Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype. Infect. Immun. 78: 3678-3688.
37. Jewett, T. J., E. R. Fischer, D. J. Mead, and T. Hackstadt. 2006. Chlamydial TARP is a bacterial nucleator of actin. Proc. Natl. Acad. Sci. USA 103: 15599-15604.
38. Mital, J., N. J. Miller, E. R. Fischer, and T. Hackstadt. 2010. Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network. Cell. Microbiol. 12: 1235-1249.
39. Stone, C. B., D. L. Johnson, D. C. Bulir, J. D. Gilchrist, and J. B. Mahony. 2008. Characterization of the putative type III secretion ATPase CdsN (Cpn0707) of Chlamydophila pneumoniae. J. Bacteriol. 190: 6580-6588.
40. Kleba, B., and R. S. Stephens. 2008. Chlamydial effector proteins localized to the host cell cytoplasmic compartment. Infect. Immun. 76: 4842-4850.